HARROWINC
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Aug 2022)
What this means for you
This application is over — abandoned 22 Aug 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88215102
- Mark type
- Stylized text
- Filed
- 03 Dec 2018
- Published for opposition
- 21 May 2019
- Abandoned
- 22 Aug 2022
- Attorney of record
- Laila S. Wolfgram
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical compositions for ophthalmological use, for anesthesiological applications, for treating fibrotic diseases, for treating male sexual disorders, for treating skin disorders, for treating kidney stones, for treating nail disorders, for treating autoimmune diseases and cancer, and for treating bleeding
Owner
- HARROW IP, LLC, Nashville, TN, US
- HARROW HEALTH, INC., SAN DIEGO, CA, US
- HARROW HEALTH, INC., SAN DIEGO, CA, US
- IMPRIMIS PHARMACEUTICALS, INC., San Diego, CA, US
Prosecution history
- 22 Aug 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Aug 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 28 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2022 — SOU EXTENSION 5 GRANTED
- 18 Jan 2022 — SOU EXTENSION 5 FILED
- 27 Jan 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Jan 2022 — SOU TEAS EXTENSION RECEIVED
- 03 Jan 2022 — ASSIGNED TO EXAMINER
- 15 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jul 2021 — SOU EXTENSION 4 GRANTED
- 13 Jul 2021 — SOU EXTENSION 4 FILED
- 13 Jul 2021 — SOU TEAS EXTENSION RECEIVED
- 12 Nov 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Nov 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Nov 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED